Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMCER: Everolimus with Early Tacrolimus Withdrawal in Liver Transplant
NCT01625377Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2012
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in Liver transplant rejection, sponsored by Novartis. Started Dec 2012; status: completed.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT01625377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625377.